bio-rap.com
Home | BioRap
http://www.bio-rap.com/Macular-Disease-AMD
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Is a rapidly growing technology transfer company that is built upon the creative innovations and patented technologies developed by the research scientists of the Rappaport Family Institute for Research in the Biomedical Sciences at the Technion.
bio-rap.com
Therapeutic Vaccines | Technologies | BioRap
http://www.bio-rap.com/Therapeutic-Vaccines
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Peptides and Binding Antibodies targeting EMMPRIN for the treatment of Cancer and Autoimmune Diseases.
bio-rap.com
Home | BioRap
http://www.bio-rap.com/index.asp?DBID=1&LNGID=1
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Is a rapidly growing technology transfer company that is built upon the creative innovations and patented technologies developed by the research scientists of the Rappaport Family Institute for Research in the Biomedical Sciences at the Technion.
bio-rap.com
Biopharmaceutical | Technologies | BioRap
http://www.bio-rap.com/Biopharmaceutical
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". One molecule with several therapeutic modalities against cancer. Peptides and Binding Antibodies targeting EMMPRIN for the treatment of Cancer and Autoimmune Diseases. New Molecules and Targets for Cancer therapy. Chronic Colitis and Colitis-Associated Cancer: Heparanase an Important Target. Cancer Suppression: Heparanase Enzyme. Diabetes: Heparanase and suppression of Diabetic Nephropathy.
bio-rap.com
Press Releases | Media Center | BioRap
http://www.bio-rap.com/Press-Releases
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research".
bio-rap.com
Home | BioRap
http://www.bio-rap.com/Forms
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Is a rapidly growing technology transfer company that is built upon the creative innovations and patented technologies developed by the research scientists of the Rappaport Family Institute for Research in the Biomedical Sciences at the Technion.
bio-rap.com
Cardiovascular | Disease Areas | Technologies | BioRap
http://www.bio-rap.com/Cardiovascular
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Optogenetics for the treatment of cardiac arrhythmias. Long QT Syndrome, CPVT and ARVC: Personalized Medicine, and Drug Development - Induced Pluripotent Stem Cells Derived Cardiomyocytes. Long QT Syndrome, CPVT and Cradiomyopathies: Drug screening and toxicity testing by Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
bio-rap.com
Disease Areas | Technologies | BioRap
http://www.bio-rap.com/Disease-Areas
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research".
bio-rap.com
Team | About Us | BioRap
http://www.bio-rap.com/Team
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". Lise Abitbol-Marciano Business Development Manager. Sara Korem Financial Manager. Lea Saragossi Administrative Assistant.
bio-rap.com
Funding Opportunities | For BioRap Inventors | BioRap
http://www.bio-rap.com/Funding-Opportunities
The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research". We facilitate collaborative research partnerships between business partners and RI researchers. Such partnerships may involve a single business partner or they may be a multi-party consortium. Each research partnership is tailored to the specific requirements of the inventor, the invention/technology, the partner, and RI. Office of the Chief Scientist grants – Kamin, Nofar. Kamin - This p...